Editor-in-Chief
Ronald W. Ellis
NasVax Ltd.
Ness Ziona, IL
Acquisitions Editor
Eva M. Riedmann
Landes Bioscience
Vienna, AT
Associate Editors
- Robert J. Amato
-
University of Texas Health Science Center
Houston, TX, US
- Martin Bachmann
-
Jenner Institute; University of Oxford
Oxford, UK
- David Baxter
-
University of Manchester Medical School
Manchester, UK
- Sujit Kumar Bhattacharya
-
National Institute of Cholera and Enteric Diseases
Kolkata, IN
- Joel Bozue
-
United States Army Medical Research Institute of Infectious Diseases
Fort Detrick, MD, US
- David Cribbs
-
University of California, Irvine School of Medicine
Irvine, CA, US
- Adil Daud
-
University of California at San Francisco
San Francisco, CA, US
- Robert S. Daum
-
University of Chicago
Chicago, IL, US
- Heather Davis
-
Pfizer Vaccines
Kanata, ON, CA
- Robert Edelman
-
University of Maryland School of Medicine
Baltimore, MD, US
- Susanna Esposito
-
University of Milan, IRCCS Policlinico
Milano, IT
- Jean-Louis Excler
-
US Military Research Program
Manila, PH
- Ian Feavers
-
National Institute for Biological Standards and Control
Potters Bar, UK
- Kristen A. Feemster
-
The Children's Hospital of Philadelphia
Philadelphia, PA, US
- Ricardo Galler
-
Instituto de Tecnologia em Imunobiologicos, Biomanguinhos
Rio de Janeiro, BR
- Nathalie Garçon
-
GlaxoSmithKline Biologicals
Rixensart, BE
- Vladimir Gilca
- Gregory Glenn
-
Novavax Inc.
Rockville, MD, US
- Andrew Gorringe
-
Health Protection Agency
Salisbury, UK
- Carlos A. Guzman
-
Helmholtz Centre for Infection Research
Braunschweig, DE
- Leonard C. Harrison
-
Walter & Eliza Hall Institute of Medical Research
Parkville, Vic, AU
- Geneviève Inchauspé
-
Transgene
Lyon, FR
- Mark A. Kane
-
Consultant
Mercer Island, WA, US
- Kevin P. Killeen
-
Matrivax Research & Development Corp
Boston, MA, US
- Hiroshi Kiyono
-
The University of Tokyo- Institute of Medical Science
Tokyo, JP
- Alex Kudrin
-
Medicines and Healthcare Products Regulatory Agency
London, UK
- C. Russell Middaugh
-
University of Kansas
Lawrence, KS, US
- Philippe Moingeon
-
Stallergenes
Antony, FR
- Mark J. Newman
-
Consultant
Smyrna, GA, US
- Charles Nicolette
-
Argos Therapeutics
Durham, NC, US
- Miguel O'Ryan
-
University of Chile
Santiago, CL
- Michael E. Pichichero
-
Rochester General Hospital Research Institute
Rochester, NY, US
- Gerald Pier
-
Harvard Medical School
Boston, MA, US
- John T. Schiller
-
National Cancer Institute
Bethesda, MD, US
- Tom Shimabukuro
-
Centers for Disease Control and Prevention
Atlanta, Georgia, US
- Jo Southern
-
Health Protection Agency
London, UK
- Daniel Speiser
-
Ludwig Institute for Cancer Research
Lausanne, CH
- Larry Steinman
-
Stanford University
Palo Alto, CA, US
- James Tartaglia
-
Sanofi Pasteur
Swiftwater, PA, US
- Kenneth E. Ugen
-
University of South Florida Morsani College of Medicine
Tampa, FL, US
- Jeffery Ulmer
-
Novartis Vaccines
Cambridge, MA, US
- Matthias von Herrath
-
Type 1 Diabetes R&D Center and Scripps Institute
San Diego, CA, US
- Brian J. Ward
-
McGill University
Montreal, QC, CA
- Michael Watson
-
Sanofi Pasteur
Lyons, FR
- Bruce G. Weniger
-
Research Institute for Health Sciences; Chiang Mai University
Bangkok, TH
Editorial Board
- Sudhir Agrawal
-
Idera Pharmaceuticals Inc.
Cambridge, MA, US
- Ruth Arnon
-
Weizmann Institute of Science
Rehovot, IL
- Steven Black
-
Kaiser Permanente
Oakland, CA, US
- Robert T. Chen
-
Centers for Disease Control and Prevention
Atlanta, GA, US
- Ron Dagan
-
Ben Gurion University
Be'er Sheva, IL
- Angus G. Dalgleish
-
St. George's Hospital Medical School
London, UK
- Anne S. De Groot
-
EpiVax Inc
Providence, RI, US
- Gordon Douglas
-
Consultant
Niantic, CT, US
- Kathryn Edwards
-
Vanderbilt University
Nashville, TN, US
- José Ezparza
-
Bill & Melinda Gates Foundation
Seattle, WA, US
- Ian H. Frazer
-
University of Queensland
Brisbane, Qld, AU
- Jaap Goudsmit
-
Crucell
Amsterdam, NL
- Dan Granoff
-
Children’s Hospital Oakland Research Institute
Oakland, CA, US
- Brian Greenwood
-
London School of Hygiene and Tropical Medicine
London, UK
- Marion Gruber
-
Food and Drug Administration
Rockland, MD, US
- Ian Gust
-
University of Melbourne
Melbourne, Vic, AU
- Scott A. Halperin
-
Dalhousie University
Halifax, NS, CA
- Michael G. Hanna, Jr
-
Vaccinogen
Frederick, MA, US
- Karl Hellstrom
-
Harborview Medical Center
Seattle, WA, US
- David C. Kaslow
-
PATH Malaria Vaccine Initiative
Washington, DC, US
- Myron M. Levine
-
University of Maryland School of Medicine
Baltimore, MD, US
- Alf Lindberg
-
Nobel Foundation
Stockholm, SE
- Thomas P. Monath
-
Kleiner Perkins Caufield & Byers
Harvard, MA, US
- Paul A. Offit
-
Children's Hospital of Philadelphia
Philadelphia, PA, US
- Stanley A. Plotkin
-
University of Pennsylvania
Philadelphia, PA, US
- Regina Rabinovich
-
Harvard School of Public Health
Cambridge, MA, US
- Philip Russell
-
Albert Sabin Vaccine Institute
Washington, DC, US
- David Salisbury
-
UK Department of Health
London, UK
- Yiming Shao
-
Chinese Center for Disease Control and Prevention
Beijing, CN
- Bing Sun
-
Chinese Academy of Sciences
Shanghai, CN
- John J. Treanor
-
University of Rochester
Rochester, NY, US
- Alexander von Gabain
-
Intercell
Vienna, AT
- David B. Weiner
-
University of Pennsylvania
Philadelphia, PA, US
- Howard L. Weiner
-
Harvard Medical School
Boston, MA, US
Advertisements
